체외진단(IVD) : 각종 기술과 세계 시장

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

The immunochemistry IVD market is expected to grow from $32.8 billion in 2024 and is projected to reach $43.0 billion by the end of 2029, at a CAGR of 5.5% during the forecast period of 2024 to 2029.

The POC testing IVD market is expected to grow from $23.2 billion in 2024 and is projected to reach $38.4 billion by the end of 2029, at a CAGR of 10.6% during the forecast period of 2024 to 2029.

Report Scope

This report covers the in vitro diagnostic (IVD) technologies as well as in vitro diagnostic devices used in hospitals and point-of-care (POC) facilities to diagnose diseases. It also details the current and future market potential of in vitro diagnostic technology and includes an analysis of this market's competitive environment. The report covers market drivers, restraints, opportunities, product approvals, regulatory scenario assessments and emerging technologies. It features market projections and estimates of the market shares of key players through 2029.

In this analysis, the in vitro diagnostics market is segmented based on technologies, applications, end users and region. Based on technologies, the market is segmented into the following categories: hematology, immunochemistry, molecular diagnostics, POC testing, clinical microbiology and tissue diagnostics. Based on applications, the in vitro diagnostics market is segmented into these categories: diabetes, nephrology, blood glucose evaluation and monitoring (BGEM), oncology, cardiology, infectious diseases and other applications. The market is segmented based on end users into diagnostic laboratories, hospitals and clinics, point-of-care centers, and other end users.

The global in vitro diagnostics market has been segmented by the following geographical regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report features detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Australia and New Zealand (ANZ), Argentina, Brazil, South Africa, Mexico and the GCC countries. Market analysis data is provided for 2023, which serves as the base year, and estimates are given for 2024 and forecast values through 2029.

Report Includes

• 41 data tables and 54 additional tables
• Analysis of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Estimates of the size of the market for in vitro diagnostics (IVD) technologies, revenues, and market shares by technology, product, application, end user and region
• Assessment of market dynamics such as drivers, restraints and opportunities
• Discussion of how the rise in the number of respiratory infections, hospital acquired infections (HAIs), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
• Discussion of IVD for neglected infectious diseases, chemistry-based portable analysis and microfluidic platform-based POC tests
• A discussion on ESG challenges and practices in the industry
• Assessment of the competitive landscape, including the market shares of key companies, their product portfolios and financial overviews
• Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments and product launches
• Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Abbott, Sysmex Corp., Danaher, BD, and Siemens Healthineers AG

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market and Technology Background

• Introduction
• In vitro Diagnostics Technology
• Overview
• Classification of In Vitro Diagnostic Elements
• Importance of In Vitro Diagnostics Technologies and Quality Control
• Difference Between In Vitro and In Vivo Diagnostics
• Regulations in the IVD Industry
• Regulation of IVD Products in Different Countries

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Rise in Population of Older Adults: Dependence on Diagnosis Procedures
• Integration of Artificial Intelligence in Vitro Diagnostics
• Rising Prevalence of Chronic Diseases
• Improving the Quality of Point-of-Care Testing (POCT)
• Market Restraints
• Challenges Associated with Technologies Product Packaging
• Increases in Shipping Costs or Service Issues
• Laboratory Assistant's Inability to Handle Laboratory Equipment and Consumables
• Market Opportunities
• Rise in Home Care Testing Devices
• Demand for Point-of-Care (POC) Testing Units
• Growing Demand for AI and the Internet of Things

Chapter 4 Emerging Technologies and Developments

• Emerging Technologies in the IVD Market
• Artificial Intelligence
• Modified Old IVD Techniques
• Liquid Biopsy
• Automated In Vitro Diagnostic Devices
• Emerging Developments in In Vitro Diagnostics
• FDA Approval
• Rise in Demand for Personalized Medicine
• Lab Automation and Digital Health Platform
• Portability Option in IVD Devices
• Home Care Kits for Cancer Diagnosis
• FDA Approved In Vitro Diagnostic Devices: AI Enabled

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Technology
• Immunochemistry
• POC Testing
• Hematology
• Molecular Diagnostics
• Tissue Diagnostics
• Clinical Microbiology
• Market Analysis by Application
• Diabetes
• Nephrology
• Blood Glucose Evaluation and Monitoring (BGEM)
• Oncology
• Cardiology
• Infectious Diseases
• Other Applications
• Market Analysis by End User
• Diagnostic Laboratory
• Hospitals and Clinics
• Point-of-Care (POC) Centers
• Other End Users
• Geographical Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Chapter 6 Competitive Intelligence

• Introduction
• Global Analysis of Company Market Ranking
• Glimpse of Leading In Vitro Diagnostics (IVD) Companies in China
• Agreements, Collaborations and Partnerships
• bioMerieux Agreements
• Siemens Healthineers and Sysmex Enter into a Global Agreement
• Roche Enters into Agreement with Path AI
• Quidel Corp. Signs Agreement to Acquire Ortho Clinical Diagnostics
• In Vitro Diagnostics Companies and Start-Ups in 2021-2023
• Diagopreutic Private Limited
• Diatherax
• IPLEXMED
• Magnify Bioscience Inc.

Chapter 7 Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective

• Importance of ESG in In Vitro Diagnostics Manufacturing Industry
• ESG Practices in the In Vitro Diagnostics Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Company Role in ESG Development
• ESG Risk Ratings
• BCC Research Viewpoint

Chapter 8 Appendix

• Research Methodology
• References
• Company Profiles
• ABBOTT
• BD
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• DANAHER CORP.
• EKF DIAGNOSTICS HOLDINGS PLC
• F. HOFFMANN-LA ROCHE LTD.
• HOLOGIC INC.
• JSR CORP.
• QUIDELORTHO CORP.
• SIEMENS HEATHNIEERS AG
• SYSMEX CORP.
• THERMO FISHER SCIENTIFIC INC.